Roivant President and Immunovant CEO Eric Venker reports sale of $7.02 million in Roivant common shares
ROIV•Eric Venker sold 200,000 Roivant common shares on Oct. 20, 2026, for about $7.02 million. His direct holdings fell to 1,399,154 shares, according to a Form 4 dated Oct. 22.
1. Share sale
Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on Oct. 20, 2026. The sales comprised 185,856 shares at $35.09 and 14,144 shares at $35.42; his direct holdings fell to 1,399,154 shares, as reported in a Form 4 dated Oct. 22.
